Efficacy of management strategies for aromatase inhibitor-induced arthralgia in breast cancer patients: a systematic review
Author:
Affiliation:
1. University of Sydney; Sydney Adventist Hospital; SAN Integrated Cancer Centre; Wahroonga New South Wales Australia
Publisher
Wiley
Subject
Oncology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/ajco.12845/fullpdf
Reference56 articles.
1. Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials;Early Breast Cancer Trialists’ Collaborative Group (EBCTCG);Lancet,2015
2. Aromatase inhibitor induced musculoskeletal syndrome: a significant problem with limited treatment options;Lombard;Support Care Cancer,2016
3. Aromatase inhibitor-induced arthralgia: a review;Niravath;Ann Oncol,2013
4. Aromatase inhibitor-associated bone and musculoskeletal effects: new evidence defining etiology and strategies for management;Gaillard;Breast Cancer Res,2011
5. Management of arthralgias associated with aromatase inhibitor therapy;Thorne;Curr Oncol,2007
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Effect of whole-body cryotherapy versus placebo cryotherapy on joint pain induced by aromatase inhibitors in women with early stage breast cancer: a randomised clinical trial;BMJ Open;2023-12
2. Declaración de consenso de la organización ejercicio y ciencias del deporte – Australia: el ejercicio como medicina en el manejo del cáncer;Pensar en Movimiento: Revista de Ciencias del Ejercicio y la Salud;2023-10-25
3. Was Unstable Medicaid Coverage Among Older Medicare Beneficiaries Associated With Worse Clinical Outcomes? Evidence From the Delivery of Breast Cancer Care;Medical Care;2023-07-13
4. Use of an alfa-lipoic, Methylsulfonylmethane, Boswellia serrata and Bromelain dietary supplement (OPERA®) for aromatase inhibitors-related arthralgia management (AIA): a prospective phase II trial (NCT04161833);Medical Oncology;2022-06-06
5. Hormonal Therapy Drug Switching, Out-of-Pocket Costs, and Adherence Among Older Women With Breast Cancer;JNCI: Journal of the National Cancer Institute;2022-03-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3